C4 Therapeutics, Inc. (CCCC)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
CCCC price, last 12 months
Key stats
- Previous close
- $3.03
- Open
- $3.03
- Day range
- $2.93 – $3.12
- 52-week range
- $1.69 – $5.17
- Volume
- 2.1M
- Avg volume (20 days)
- 2M
- Market cap
- $366.6M
Performance
Technicals and fundamentals
About C4 Therapeutics, Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $366.6M